A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients - Qunibi, Wajeh Y.; Martinez, Carlos; Smith, Mark; Benjamin, Joseph; Mangione, Antoinette; Roger, Simon D. (Nephrology, dialysis, transplantation, 2011)
Keywords: Administration, Oral; Aged; Anemia, Iron-Deficiency - drug therapy; Anemia, Iron-Deficiency - etiology; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Biological and medical sciences; Blood. Blood coagulation. Reticuloendothelial system; Emergency and intensive care: renal failure. Dialysis management; Female; Ferric Compounds - administration & dosage; Glomerular Filtration Rate; Humans; Injections, Intravenous; Intensive care medicine; Iron - administration & dosage; Kidney Failure, Chronic - complications; Kidney Failure, Chronic - drug therapy; Male; Maltose - administration & dosage; Maltose - analogs & derivatives; Medical sciences; Original; Pharmacology. Drug treatments; Prognosis; Human; Kidney disease; intravenous iron; transferrin saturation; Transferrin; Urinary system disease; Intravenous administration; anaemia; Hemodialysis; Deficiency; Saturation; Ferritin; Oral administration; Iron; Ferric carboxymaltose; Extrarenal dialysis; Treatment; Renal failure; Dialysis; CKD